Cited by 6Attention Deficit Hyperactivity DisorderGrowth Hormone and Insulin-like Growth FactorsPharmaceutical studies and practices

Effect of stimulants on final adult height

Open access
Wojnowski, Natalia M., Zhou, Elaine, Jee, Youn Hee·2022·Journal of Pediatric Endocrinology and Metabolism

Abstract

BACKGROUND: The use of stimulant medications for treatment of ADHD has raised concern as to whether they adversely impact linear growth. Previous studies have indicated that stimulant medications may suppress growth for a short period after treatment initiation; however, more information is needed to evaluate the long-term effects on final adult stature. This mini review aims to evaluate the effect of stimulant medications on final adult height in children with ADHD. CONTENTS: We performed a literature review across PubMed/MEDLINE database. Only articles that included data on final adult height or near final adult height (age≥16 or 17 years) were included. SUMMARY: Early studies investigating the long-term impacts of stimulant medications observed growth suppression during the active treatment period, but when comparing final adult height, there was no difference between the control and ADHD groups. A recent larger comprehensive study (Multimodal Treatment of ADHD study) has suggested that the long-term use of significant doses of stimulants during childhood may compromise final adult height to a clinically significant degree when comparing adult height across three long-term patterns of stimulant treatment (Consistent, Intermittent, Negligible). The consistent use subgroup was significantly shorter than other subgroups. OUTLOOK: For children with ADHD, a significant long-term dose of stimulant treatment should be used with caution to avoid diminishing adult height potential. Pediatric endocrinologists should consider chronic use of stimulants as a factor contributing to reduced adult height.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/jpem-2022-0344

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Concerns regarding misuse and diversion of stimulants remain relevant, particularly among young adults and university populations.

    “Concerns regarding misuse and diversion remain relevant, particularly among young adults and university populations [150].”

    From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [150]

    The Introduction discusses prescribed stimulants in children and concerns about cardiovascular effects and growth suppression; the Abstract also focuses on growth and adult height. Searches for misuse, diversion, and nonmedical use among young adults or university populations found no passage addressing the cited claim. No page numbers were available in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wojnowski, N. M., Zhou, E., & Jee, Y. H.
Affiliations
National Institutes of Health (US)
Corresponding author
Jee, Youn Hee
Venue
Journal of Pediatric Endocrinology and Metabolism
Published
2022-10-05
Volume
35
Issue
11
Pages
1337-1344
ISSN
  • 0334-018X (ISSN-L)
  • 2191-0251
OpenAlex
W4301390984
Cited by
6
References
30
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1
FWCI
0.81
Type
journal article
Language
en
Open access
Locations
  • Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
stimulant medication, attention deficit hyperactivity disorder, adult height, linear growth, growth inhibition, pediatric endocrinology
MeSH terms
Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Body Height, Child, Combined Modality Therapy, Humans, Databases, Factual

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review